4 completed, 1 terminated. 2 Phase 1, 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 3 | 1 | Completed 1 |
Follow Impel Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| INP105 Proof-of-concept Study for the Acute Treatment of Agitation in Adolescents and Young Adults With ASD INP105, Placebo - Agitation in Adolescents and Young Adults With ASD | Phase 2 | Terminated | Impel Pharmaceuticals | 8 | 2022-06-23 | 2023-09-28 |
| Safety and Tolerability of INP105 (Olanzapine by I231 POD® Device) Nasal Spray in Healthy Volunteers - SNAP 101 Zyprexa IM, Zydis, INP105 - Acute Agitation | Phase 1 | Completed | Impel Pharmaceuticals | 38 | 2018-08-05 | 2018-10-04 |
| Safety and Tolerability of POD-DHE (INP104) in Migraine (STOP 301) INP104 - Migraine Headache | Phase 3 | Completed | Impel Pharmaceuticals | 360 | 2018-07-13 | 2021-03-11 |
| Therapeutic Potential for Intranasal Levodopa in Parkinson's Disease -Off Reversal Placebo, L-dopa 35 mg, L-dopa 70mg - Parkinson's Disease | Phase 2 | Completed | Impel Pharmaceuticals | 32 | 2018-05-08 | 2020-08-12 |
| Bioavailability of DHE Administered by I123 POD Device, IV Injection, and Migranal Nasal Spray in Healthy Adults INP104, Dihydroergotamine Mesylate (DHE), Migranal Nasal Spray - Migraine Headache | Phase 1 | Completed | Impel Pharmaceuticals | 36 | 2017-10-19 | 2019-03-15 |
Migraine Disorders (2) · Psychomotor Agitation (2) · Autistic Disorder (1) · Parkinson Disease (1) · Schizophrenia (1)
Dihydroergotamine (2) · Carbidopa (1) · Levodopa (1) · Olanzapine (1)
Australia (3) · United States (2)
Stephen B Shrewsbury, MD (2) · Craig Erickson, MD (1) · Jason Lickliter, MD (1) · Matthew Siegel, MD (1) · Niquita Tugiono, MD (1) · Stephen Shrewsbury, MD (1) · Terry O'Brien, MD/Prof (1)